Final clinical diagnosis was Kallmann syndrome (partial central hypogonadism, with a dissociated axis function showing a more affected LH-Leydig cell than FSH-Sertoli cells axis), and he was started again on testosterone enanthate 100 mg per month, with progressive increases up to 250 mg. This evidence concerns the gene BRD2 and hypogonadotropic hypogonadism.